from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1475c/acn

LFCtreatmentdescriptionclass of inhibitor

1.808

Amikacinug/mL Amikacintranslation

1.711

Cap5-10ug/mL Capreomycintranslation

1.824

Rox10-50 ug/mL Roxithromycintranslation

0.882

SM2-5 ug/mL Streptomycintranslation

1.580

Tet5-10 ug/mL Tetracyclinetranslation

-0.825

Rif0.2-5ug/mL Rifampicintranscription

-0.125

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.301

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.412

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.306

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.430

Clofazimine10-13 ug/mL Clofaziminerespiration

0.224

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.841

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.312

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.212

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.421

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.811

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.524

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.712

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.390

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.990

KCN5-20 ug/mL Potassium cyaniderespiration

0.381

NaN30.2-2 mM Sodium aziderespiration

0.003

Nigericin50 uM Nigericinrespiration

-0.277

TRC10-150 ug/mL Triclosanrespiration

0.075

TRZ10-25 ug/mL Thioridazinerespiration

-0.377

Valinomycin0.5-10 uM Valinomycinrespiration

0.289

ZnSO42 mM ZnSO4respiration

2.633

menadione6-10 ug/mL Menadionerespiration

-2.251

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.817

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-2.006

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.103

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.192

NRP_1Non-replicating persistence stage 1dosRassociated

0.122

Amp0.2mg/mL AmpicillincellWall

0.055

Cephalexin20-100 ug/mL CephalexincellWall

0.827

Cerulenin0.32-5 ug/mL CerulenincellWall

0.290

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.004

EMB10-20 ug/mL EthambutolcellWall

0.165

Eta12-40 ug/mL EthionamidecellWall

-0.354

INH0.2-0.4 ug/mL IsoniazidcellWall

0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.052

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.008

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.913

BZA0.12 mg/mL BenzamidearomaticAmides

0.395

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.122

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.793

H2O24 mM hydrogen peroxideDNAdamaging

0.789

Levo10 ug/mL LevofloxacinDNAdamaging

0.476

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.184

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.584

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.003

UVUV-irradiationDNAdamaging

-0.672

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.316

Antimycin12.5-50 ug/mL Antimycin A?

-0.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.188

PA_110-50 ug/mL Antitubercular compound PA-1?

0.313

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.806

PA8240.2-2 ug/mL PA-824?

-0.276

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.669

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.212

Verapamil50 uM Verapamil?

0.030

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.130

methoxatin10-20 ug/mL Methoxatin?